Proprotein Convertase 9
Medicine & Life Sciences
100%
Mouse Pcsk9 protein
Medicine & Life Sciences
75%
Non-alcoholic Fatty Liver Disease
Medicine & Life Sciences
73%
In Situ Hybridization
Medicine & Life Sciences
62%
Carcinogenesis
Medicine & Life Sciences
52%
Cholesterol
Medicine & Life Sciences
50%
Immunohistochemistry
Medicine & Life Sciences
47%
Breast Neoplasms
Medicine & Life Sciences
43%
Ioannou, G. N. ,
Lee, S. P. ,
Linsley, P. S. ,
Gersuk, V. ,
Yeh, M. M. ,
Chen, Y. Y. ,
Peng, Y. J. ,
Dutta, M. ,
Mascarinas, G. ,
Molla, B. ,
Cui, J. Y. &
Savard, C. ,
4月 2022 ,
於: Hepatology Communications. 6 ,
4 ,
p. 780-794 15 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Proprotein Convertase 9
100%
Mouse Pcsk9 protein
75%
Non-alcoholic Fatty Liver Disease
73%
Carcinogenesis
52%
Cholesterol
50%
In Situ Hybridization
100%
Immunohistochemistry
76%
Breast Neoplasms
69%
Immunoconjugates
16%
Trastuzumab
14%